Inflammatory bowel disease patients undergoing total hip arthroplasty have higher odds of implant-related complications
HIP International · 2024
DOI: 10.1177/11207000231214768 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIP International, 2024. Verfasst von Matthew L Magruder und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Inflammatory Bowel Diseases, Postoperative Complications. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Purpose
This study evaluates whether IBD patients are at increased risk of implant-related complications after THA. Materials and methods: A retrospective study from 01 January 2010 to 31 October 31 2020 using an administrative claims database was performed. IBD patients undergoing THA ( n = 11,025), without corticosteroid treatment, were propensity score matched to controls in a 1:5 ratio ( n = 55,121) based on age, sex, and the Charlson Comorbidity Index (CCI). Outcomes evaluated included periprosthetic fracture, aseptic loosening, prosthetic joint infection, and THA revision within 2 years of index procedure. Chi-square analyses were used to compare the matched cohorts. The association of IBD and implant-related complications was evaluated using logistical regression to calculate odds ratios (ORs), 95% confidence intervals (95% CIs), and p-values. A p-value < 0.001 was used as the significance threshold.
Results
Patients with IBD had a greater incidence and odds of total implant complications (7.03% vs. 3.98%; OR 1.76; p < 0.001) compared with matched controls. IBD patients had significantly higher incidence and odds of developing periprosthetic fracture (0.50% vs. 0.20%; OR 2.46; p < 0.001), THA revisions (2.21% vs. 1.17%; OR 1.91; p < 0.001), aseptic loosening (1.45% vs. 0.84%; OR 1.75; p < 0.001), and prosthetic joint infection (2.87% vs. 1.77%; OR 1.64; p < 0.001).
Conclusions
Patients with IBD who underwent primary THA had a significantly higher risk of implant-related complications compared to matched controls. Providers should use this study to appropriately assess post-complication risk factors for their patients with IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, NY, USA.
- Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA.
ORCID-Profile: Shabnam Parsa
Zitieren
APA
Magruder, M. L., Parsa, S., Gordon, A. M., Ng, M., & Wong, C. H. J. (2024). Inflammatory bowel disease patients undergoing total hip arthroplasty have higher odds of implant-related complications. HIP International. https://doi.org/10.1177/11207000231214768
Vancouver
Magruder ML, Parsa S, Gordon AM, Ng M, Wong CHJ. Inflammatory bowel disease patients undergoing total hip arthroplasty have higher odds of implant-related complications. HIP International. 2024. doi:10.1177/11207000231214768
BibTeX
@article{Magruder2024,
author = {Magruder, Matthew L and Parsa, Shabnam and Gordon, Adam M and Ng, Mitchell and Wong, Che Hang J},
title = {Inflammatory bowel disease patients undergoing total hip arthroplasty have higher odds of implant-related complications},
journal = {HIP International},
year = {2024},
doi = {10.1177/11207000231214768}
}
EUVIMED